Wednesday, February 10, 2010, 1:00PM AEST - The Australian Stockmarket closes in 3 hours and 5 minutes.
To create a watchlist or portfolio of shares, Register

Electro-Optical Sciences, Inc. (MELA)

8:00AM AEST: 8.83 USD  Up 0.06 (0.68%)  
 MORE ON MELA 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Electro-Optical Sciences, Inc (NCM:MELA) Delayed quote dataEdit
Last Trade:8.83 USD
Trade Time: 8:00AM AEST
Change:Up 0.06 (0.68%)
Prev Close:8.77
Open:8.90
Bid:8.65 x 700
Ask:9.23 x 200
1y Target Est:10.95
Day's Range:8.70 - 8.99
52wk Range:3.50 - 12.24
Volume:212,987
Avg Vol (3m):427,657
Market Cap:196.44M
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add MELA to Portfolio   Download Data

 HEADLINES 
3 Stocks Hitting High Notes
at Motley Fool (Fri, Jan 15)
ELECTRO OPTICAL SCIENCES INC /NY Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Jan 12)
Electro-Optical Sciences Appoints Charles Stiefel to Board of Directors
Marketwire (Tue, Jan 12)
Peter Brimelow: 2009 top performer sees V-shaped recovery
at MarketWatch (Fri, Jan 8)
Profit Whichever Way a Stock Goes
at Motley Fool (Sat, Dec 12)
Electro-Optical Sciences Announces Participation at 12th Annual Needham Growth Conference
Marketwire (Tue, Dec 8)
Coverage initiated on Electro Optical Sciences by WBB Securities
Briefing.com (Tue, Dec 1)
ELECTRO OPTICAL SCIENCES INC /NY Financials
EDGAR Online Financials (Sat, Nov 14)
Electro-Optical Sciences to Present at Upcoming Investor Conferences
Marketwire (Thu, Nov 12)
ELECTRO OPTICAL SCIENCES INC /NY Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 10)
More Headlines for MELA...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.94
EPS Est (in 2 years) (Dec-10) :-0.95
Avg Rec (current)*:2.4
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Electro-Optical Sciences, Inc., a medical device company, focuses on the design, development, and commercialization of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma in the United States and internationally.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices